EASL Studio13 Dec at 18:00 CETHepatic encephalopathy: Underdiagnosed and underestimatedLearn moreRe-watch the last episode Next ERN webinar12 Dec 2023, 17:00 CETAlpha-1 antitrypsin deficiency: a poster child for nucleic acid therapyRegister nowRewatch the last webinar EASL Policy DialoguesSeason 2 Episode 8 now available!The political battle to reduce harms caused by alcoholWatch nowRe-watch the last episode EASL QuizBrand new and challengingElevate your hepatology expertise!Take the QuizSee all EASL Quiz EASL Molecular Tumour BoardNow on demand!Molecular Tumour Board in HCC: Is it possible and/or practical?Watch it EASL Journal ClubNow on demand!Inflamed and non-inflamed class of HCC: A revised immunogenomic classificationWatch itSee all EASL Journal Club EASL LCS 202422-24 February 2024 Join the future of liver cancer care in Rotterdam (The Netherlands)Register now EASL SLD Summit 2023Now on-demand!For registered delegates only.Access now! Topics Basic Science 846 Resources 2 Languages View Cirrhosis & Complications 1491 Resources 5 Languages View General Hepatology 2632 Resources 4 Languages View Immune-Mediated and Cholestatic Diseases 640 Resources 3 Languages View Liver Tumours 1924 Resources 3 Languages View Metabolism, Alcohol & Toxicity 2667 Resources 6 Languages View Viral Hepatitis 2150 Resources 13 Languages View News & articles Liver Cancer Awareness Month 2023 Oct 10 2023 World Hepatitis Day Jul 28 2023 Latest EASL CPGs Jul 06 2023 EASL Congress 2023 Jul 04 2023 You may also be interested in Online Courses Discover the eLearning offering and obtain up to 40 CME credits! View EASL Molecular Tumour Board on intrahepatic cholangiocarcinoma This EASL-MTB was held on 23 May 2023 and discussed a clinical case of intrahepatic cholangiocarcinoma (CCA). View EASL Journal Club Look at all the Journal Clubs available so far and continue the discussion with the community! View Basic Techniques in Experimental Hepatology at a Glance Lean more about this educational offering illustrating scientific video protocols in the fields of hepatology and liver-related research. View EASL Campus is supported by: GSK Boehringer Ingelheim GSK and Boehringer Ingelheim have had no input into the EASL content of EASL Campus.